Literature DB >> 28347235

Selection of single chain antibody fragments binding to the extracellular domain of 4-1BB receptor by phage display technology.

Salman Bagheri1,2,3, Mehdi Yousefi1,2, Elmira Safaie Qamsari1,2,3, Farhad Riazi-Rad4, Mohsen Abolhassani3, Vahid Younesi5, Ruhollah Dorostkar6, Ali Akbar Movassaghpour2, Zahra Sharifzadeh3.   

Abstract

The 4-1BB is a surface glycoprotein that pertains to the tumor necrosis factor-receptor family. There is compelling evidence suggesting important roles for 4-1BB in the immune response, including cell activation and proliferation and also cytokine induction. Because of encouraging results of different agonistic monoclonal antibodies against 4-1BB in the treatment of cancer, infectious, and autoimmune diseases, 4-1BB has been suggested as an attractive target for immunotherapy. In this study, single chain variable fragment phage display libraries, Tomlinson I+J, were screened against specific synthetic oligopeptides (peptides I and II) designed from 4-1BB extracellular domain. Five rounds of panning led to selection of four 4-1BB specific single chain variable fragments (PI.12, PI.42, PII.16, and PII.29) which showed specific reaction to relevant peptides in phage enzyme-linked immunosorbent assay. The selected clones were successfully expressed in Escherichia coli Rosetta-gami 2, and their expression was confirmed by western blot analysis. Enzyme-linked immunosorbent assay experiments indicated that these antibodies were able to specifically recognize 4-1BB without any cross-reactivity with other antigens. Flow cytometry analysis demonstrated an acceptable specific binding of the single chain variable fragments to 4-1BB expressed on CCRF-CEM cells, while no binding was observed with an irrelevant antibody. Anti-4-1BB single chain variable fragments enhanced surface CD69 expression and interleukin-2 production in stimulated CCRF-CEM cells which confirmed the agonistic effect of the selected single chain variable fragments. The data from this study have provided a rationale for further experiments involving the biological functions of anti-4-1BB single chain variable fragments in future studies.

Entities:  

Keywords:  4-1BB; T cell; cancer; immunotherapy; phage display; single chain variable fragment

Mesh:

Substances:

Year:  2017        PMID: 28347235     DOI: 10.1177/1010428317695924

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  9 in total

Review 1.  Agonist antibody discovery: Experimental, computational, and rational engineering approaches.

Authors:  John S Schardt; Harkamal S Jhajj; Ryen L O'Meara; Timon S Lwo; Matthew D Smith; Peter M Tessier
Journal:  Drug Discov Today       Date:  2021-09-24       Impact factor: 7.851

2.  Identification of an anti-SARS-CoV-2 receptor-binding domain-directed human monoclonal antibody from a naïve semisynthetic library.

Authors:  Hilal Ahmad Parray; Adarsh Kumar Chiranjivi; Shailendra Asthana; Naveen Yadav; Tripti Shrivastava; Shailendra Mani; Chandresh Sharma; Preeti Vishwakarma; Supratik Das; Kamal Pindari; Subrata Sinha; Sweety Samal; Shubbir Ahmed; Rajesh Kumar
Journal:  J Biol Chem       Date:  2020-07-29       Impact factor: 5.157

Review 3.  T7 Phage as an Emerging Nanobiomaterial with Genetically Tunable Target Specificity.

Authors:  Hui Yue; Yan Li; Mingying Yang; Chuanbin Mao
Journal:  Adv Sci (Weinh)       Date:  2021-12-16       Impact factor: 16.806

4.  Development of a human phage display-derived anti-PD-1 scFv antibody: an attractive tool for immune checkpoint therapy.

Authors:  Sepideh Safaei Ghaderi; Farhad Riazi-Rad; Elmira Safaie Qamsari; Salman Bagheri; Fatemeh Rahimi-Jamnani; Zahra Sharifzadeh
Journal:  BMC Biotechnol       Date:  2022-08-23       Impact factor: 3.329

5.  New Anti-Flavivirus Fusion Loop Human Antibodies with Zika Virus-Neutralizing Potential.

Authors:  Renato Kaylan Alves de Oliveira França; Jacyelle Medeiros Silva; Lucas Silva Rodrigues; Dimitri Sokolowskei; Marcelo Macedo Brigido; Andrea Queiroz Maranhão
Journal:  Int J Mol Sci       Date:  2022-07-15       Impact factor: 6.208

6.  A Single Domain-Based Anti-Her2 Antibody Has Potent Antitumor Activities.

Authors:  Xiaoqiong Wu; Siqi Chen; Limin Lin; Jiayu Liu; Yanlan Wang; Yumei Li; Qing Li; Zhong Wang
Journal:  Transl Oncol       Date:  2018-02-20       Impact factor: 4.243

7.  Targeting the 4-1BB costimulatory molecule through single chain antibodies promotes the human T-cell response.

Authors:  Salman Bagheri; Elmira Safaie Qamsari; Mehdi Yousefi; Farhad Riazi-Rad; Zahra Sharifzadeh
Journal:  Cell Mol Biol Lett       Date:  2020-04-22       Impact factor: 5.787

8.  Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma.

Authors:  Lijie Xia; Qiao Teng; Qi Chen; Fuchun Zhang
Journal:  Int J Nanomedicine       Date:  2020-03-30

9.  Selection of a Single Domain Antibody, Specific for an HLA-Bound Epitope of the Mycobacterial Ag85B Antigen.

Authors:  Paola A Ortega; Mayra Silva-Miranda; Alfredo Torres-Larios; Eduardo Campos-Chávez; Kees C L C M Franken; Tom H M Ottenhoff; Juraj Ivanyi; Clara Espitia
Journal:  Front Immunol       Date:  2020-10-02       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.